Biotech returning to favor “After a nearly four-year slowdown, money is beginning to flow again into the biotechnology sector. But […]

Drug firms in United States, Europe move biotech work to India “Drug makers in the United States and Europe are

Singapore Wants You! “The future-friendly city-state has an offer bioscientists can’t refuse: unrestricted research, top-notch equipment, and limitless funds. (Just

Biotech’s Longer Convalescence “The biotech sector has fallen, and it doesn’t seem able to get up. “

Biotech’s Longer Convalescence “The biotech sector has fallen, and it doesn’t seem able to get up. “

China: how to seize “commanding point” of biotechnology “China’s capital investment in the scientific research of life science is far

China: how to seize “commanding point” of biotechnology “China’s capital investment in the scientific research of life science is far

Stem-Cell Cash on a Winding Road They may not be investing in the companies themselves, but venture capitalists haven’t completely

Financial Snapshot For June 2004 Lackluster Performance

ImClone Hammered as Sales Lag Estimates Scandal-plagued ImClone Systems may have fallen off the road to recovery. While the company’s